Cargando…

Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing

This paper describes nine instances of positive anti-doping tests that could be accounted for by the use of permitted generic prescription drugs contaminated with diuretics, which are prohibited in sport at all times under the WADA Prohibited List. The contamination levels found in the medications a...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichner, Amy, Lewis, Laura A., Leonard, Bridget, Wagoner, Ryan M. Van, Eichner, Daniel, Fedoruk, Matthew N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635962/
https://www.ncbi.nlm.nih.gov/pubmed/34870192
http://dx.doi.org/10.3389/fspor.2021.692244
_version_ 1784608433767448576
author Eichner, Amy
Lewis, Laura A.
Leonard, Bridget
Wagoner, Ryan M. Van
Eichner, Daniel
Fedoruk, Matthew N.
author_facet Eichner, Amy
Lewis, Laura A.
Leonard, Bridget
Wagoner, Ryan M. Van
Eichner, Daniel
Fedoruk, Matthew N.
author_sort Eichner, Amy
collection PubMed
description This paper describes nine instances of positive anti-doping tests that could be accounted for by the use of permitted generic prescription drugs contaminated with diuretics, which are prohibited in sport at all times under the WADA Prohibited List. The contamination levels found in the medications are reported and were below FDA limits for manufacturers that are based primarily on safety considerations. These cases demonstrate that great care must be taken to identify the source of low-level anti-doping positives for diuretics reported by WADA-accredited laboratories, and possibly other prohibited substances as well, in order to avoid sanctioning innocent athletes. An evaluation of the cases in this paper supports an approach which establishes a laboratory minimum reporting level (MRL) for diuretics found most commonly in medications. A global consensus after extensive review of similar anti-doping cases has resulted in implementation of a recently announced solution regarding potential diuretic contamination cases.
format Online
Article
Text
id pubmed-8635962
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86359622021-12-02 Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing Eichner, Amy Lewis, Laura A. Leonard, Bridget Wagoner, Ryan M. Van Eichner, Daniel Fedoruk, Matthew N. Front Sports Act Living Sports and Active Living This paper describes nine instances of positive anti-doping tests that could be accounted for by the use of permitted generic prescription drugs contaminated with diuretics, which are prohibited in sport at all times under the WADA Prohibited List. The contamination levels found in the medications are reported and were below FDA limits for manufacturers that are based primarily on safety considerations. These cases demonstrate that great care must be taken to identify the source of low-level anti-doping positives for diuretics reported by WADA-accredited laboratories, and possibly other prohibited substances as well, in order to avoid sanctioning innocent athletes. An evaluation of the cases in this paper supports an approach which establishes a laboratory minimum reporting level (MRL) for diuretics found most commonly in medications. A global consensus after extensive review of similar anti-doping cases has resulted in implementation of a recently announced solution regarding potential diuretic contamination cases. Frontiers Media S.A. 2021-11-18 /pmc/articles/PMC8635962/ /pubmed/34870192 http://dx.doi.org/10.3389/fspor.2021.692244 Text en Copyright © 2021 Eichner, Lewis, Leonard, Wagoner, Eichner and Fedoruk. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Sports and Active Living
Eichner, Amy
Lewis, Laura A.
Leonard, Bridget
Wagoner, Ryan M. Van
Eichner, Daniel
Fedoruk, Matthew N.
Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
title Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
title_full Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
title_fullStr Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
title_full_unstemmed Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
title_short Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
title_sort generic pharmaceuticals as a source of diuretic contamination in athletes subject to sport drug testing
topic Sports and Active Living
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635962/
https://www.ncbi.nlm.nih.gov/pubmed/34870192
http://dx.doi.org/10.3389/fspor.2021.692244
work_keys_str_mv AT eichneramy genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting
AT lewislauraa genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting
AT leonardbridget genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting
AT wagonerryanmvan genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting
AT eichnerdaniel genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting
AT fedorukmatthewn genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting